Effects of inhibition of glycation and oxidative stress on the development of diabetic nephropathy in rats

被引:44
作者
Agardh, CD
Stenram, U
Torffvit, O
Agardh, E
机构
[1] Univ Hosp MAS, Wallenberg Res Lab, SE-20502 Malmo, Sweden
[2] Univ Lund Hosp, Dept Pathol, S-22185 Lund, Sweden
[3] Univ Lund Hosp, Dept Med, S-22185 Lund, Sweden
关键词
aminoguanidine; probucol; albumin; tamm-horsfall protein; urine; nephropathy; diabetes; rat;
D O I
10.1016/S1056-8727(02)00164-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We investigated whether aminoguanidine (AG), an inhibitor of advanced glycated end product formation, or probucol (PB), a free radical scavenger, could influence signs of glomerular and distal tubular function and morphological changes in kidneys of male Wistar rats after 6 months of streptozoein (STZ)-induced diabetes. Diabetic rats had a higher kidney weight/body weight ratio (P < .001), but neither AG nor PB influenced the increased ratio. Diabetes caused an increased urinary albumin excretion (P < .05), which was normalized by AG, but further exaggerated by PB (P < .001). Diabetes also caused an increase in the urinary excretion of Tamm-Horsfall protein (P < .001). Both AG and PB attenuated this increase (P < .05 for both). A few glomeruli displayed focal thickening of varying degrees. Silver staining disclosed the glomerulopathy to be intercapillary glomerulosclerosis. Rats on PB-enriched diet displayed less pronounced changes than untreated rats (P < .01), while AG had no effect. The results suggest that oxidative stress could be involved in the development of diabetic nephropathy. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:395 / 400
页数:6
相关论文
共 39 条
  • [1] Agardh E, 2000, CURR EYE RES, V21, P543, DOI 10.1076/0271-3683(200007)21:1
  • [2] 1-Z
  • [3] FT543
  • [4] Quenching of reactive oxidative species by probucol and comparison with other antioxidants
    Bisby, RH
    Johnson, SA
    Parker, AW
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 1996, 20 (03) : 411 - 420
  • [5] ADVANCED PROTEIN GLYCOSYLATION IN DIABETES AND AGING
    BROWNLEE, M
    [J]. ANNUAL REVIEW OF MEDICINE, 1995, 46 : 223 - 234
  • [6] AMINOGUANIDINE PREVENTS DIABETES-INDUCED ARTERIAL-WALL PROTEIN CROSS-LINKING
    BROWNLEE, M
    VLASSARA, H
    KOONEY, A
    ULRICH, P
    CERAMI, A
    [J]. SCIENCE, 1986, 232 (4758) : 1629 - 1632
  • [7] High-dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with type 1 diabetes
    Bursell, SE
    Clermont, AC
    Aiello, LP
    Aiello, LM
    Schlossman, DK
    Feener, EP
    Laffel, L
    King, GL
    [J]. DIABETES CARE, 1999, 22 (08) : 1245 - 1251
  • [8] LAMININ ALTERATIONS AFTER INVITRO NONENZYMATIC GLYCOSYLATION
    CHARONIS, AS
    REGER, LA
    DEGE, JE
    KOUZIKOLIAKOS, K
    FURCHT, LT
    WOHLHUETER, RM
    TSILIBARY, EC
    [J]. DIABETES, 1990, 39 (07) : 807 - 814
  • [9] PREVENTION OF DIABETIC NEPHROPATHY IN DB/DB MICE WITH GLYCATED ALBUMIN ANTAGONISTS - A NOVEL TREATMENT STRATEGY
    COHEN, MP
    SHARMA, K
    JIN, YL
    HUD, E
    WU, VY
    TOMASZEWSKI, J
    ZIYADEH, FN
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (05) : 2338 - 2345
  • [10] Cohen MP, 1996, DIABETOLOGIA, V39, P270